Anusol HC (hydrocortisone) NDC 65649-401

NDC codes

FDA NDC Directory

Product NDC (as listed)65649-401Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65649-0401Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65649-401-30	65649040130	1 TUBE in 1 CARTON (65649-401-30) / 30 g in 1 TUBEMarketed from Jun 6, 1984

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Anusol HCSuffix: HC
Generic name (nonproprietary): hydrocortisone
Active ingredients: Hydrocortisone — 25 mg/g
Dosage form: Cream
Route: Topical
Labeler: Salix Pharmaceuticals, Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 088250
Marketing start: Jun 6, 1984
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 65649-401_1103c6ea-1e5c-465c-bae8-9d56dfa9a7cdSPL ID 1103c6ea-1e5c-465c-bae8-9d56dfa9a7cdSPL set ID 5a0439c8-50a0-4f85-9cb4-9e3a5b0c31e7RxCUI 310891, 1659445UNII WI4X0X7BPJ
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465649040130 followed by a unit qualifier and the quantity

Package 65649-0401-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 1, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)